Incidence and mitigation of gastrointestinal events in patients with relapsing-remitting multiple sclerosis receiving delayed-release dimethyl fumarate: a German phase IV study (TOLERATE).

Gold, Ralf; Schlegel, Eugen; Elias-Hamp, Birte; Albert, Christian; Schmidt, Stephan; Tackenberg, Björn; Xiao, James; Schaak, Tom; Salmen, Hans Christian

Gold, Ralf; Schlegel, Eugen; Elias-Hamp, Birte; Albert, Christian; Schmidt, Stephan; Tackenberg, Björn; Xiao, James; Schaak, Tom; Salmen, Hans Christian.

Afiliación

Gold R; Katholisches Klinikum Bochum St. Josef-Hospital, Neurological Clinic, Bochum University, Gudrunstraße 56, 44791 Bochum, Germany.
Schlegel E; Centre for Neurological Studies, Siegen, Germany.
Elias-Hamp B; Institute for Clinical Studies, Hamburg, Germany.
Albert C; Neurological Clinic, St. Josef Hospital, Potsdam, Germany.
Schmidt S; Neurological Study Centre, Bonn, Germany.
Tackenberg B; Department of Neurology, Marburg University, Marburg, Germany.
Xiao J; Biogen, Cambridge, MA, USA.
Schaak T; Biogen, Ismaning, Germany.
Salmen HC; Biogen, Ismaning, Germany.

Ther Adv Neurol Disord ; 11: 1756286418768775, 2018.

Article en En | MEDLINE | ID: mdl-29707040

Palabras clave

dimethyl fumarate; gastrointestinal events; multiple sclerosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Incidence_studies / Risk_factors_studies Idioma: En Revista: Ther Adv Neurol Disord Año: 2018 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google